Introduction

DRCOAT® and DRUGCOAT® are both tablet coating systems, but they solve different problems. DRUGCOAT® is a range of raw methacrylate-based polymers built for functional coating work: enteric protection, taste masking and sustained release. DRCOAT® is a range of ready-to-use coating systems, pre-formulated so a formulator can disperse and coat without building the formulation from raw polymer first.

The confusion usually comes from the fact that both ranges include enteric coating options. This makes it look like the choice is about the type of release, when it is actually about how much formulation work you want to do yourself. A formulator who needs a custom enteric release profile, a taste masking layer or sustained release control has a reason to work with DRUGCOAT® polymers directly. A formulator who needs a reliable, fast coating for immediate release, moisture protection or a cosmetic finish is usually better served by a ready-to-use DRCOAT® system.

At Vikram Thermo (India) Ltd., we supply both ranges. The right answer depends on the product being coated, not on which name sounds more advanced. This article sets out how to make that call.

What DRCOAT and DRUGCOAT Actually Are

DRUGCOAT® polymers, part of our range of pharmaceutical coating polymers, are supplied as raw material. A formulator dissolves or disperses the polymer, adjusts it with plasticizers and other additives and builds a coating formulation suited to the specific product. This gives full control over the release profile, but it requires formulation expertise and development time.

DRCOAT® is a ready-to-use tablet coating system supplied pre-formulated. The polymer, plasticizer and other functional ingredients are already combined in the correct ratio. A formulator disperses the system in water or solvent and coats directly, without a separate formulation step. This is faster and requires less in-house formulation work, but it offers less room to customize the release behavior beyond what the system is designed for.

Both ranges sit within functional excipients pharmaceutical teams rely on daily. Neither range is better in general. The right one depends on what the coating actually needs to do.

‍

Why It Matters

Choosing the wrong range does not usually cause a coating to fail outright. It shows up as wasted time and cost instead. A formulator who starts with DRUGCOAT® polymers to build a simple cosmetic finish spends development time on a formulation step that a ready-to-use DRCOAT® system would have skipped entirely. A formulator who starts with a DRCOAT® ready-to-use system for a sustained release product will find that no ready-to-use option exists for that release type, since DRUGCOAT® is the only range built for it.

Getting this decision right early avoids both problems. It also shapes the sampling process. A formulator who requests the wrong range first often has to restart the evaluation once the actual requirement becomes clear.

The Decision Framework

Four questions narrow the choice quickly.

Does the product need sustained or delayed release control?

DRUGCOAT® is the only sustained release coating polymer range built for this. The RL, RS and NE series are designed specifically for pH-independent or time-based release. DRCOAT® has no ready-to-use equivalent for this function.

Does the product need taste masking?

DRUGCOAT® E series is our taste masking coating polymer built for this. DRCOAT® does not currently offer a ready-to-use taste masking system.

Does the product need enteric protection?

Both ranges include an enteric coating polymer option, which is where the real decision sits. DRUGCOAT® L and S series polymers give control over the exact pH release point and allow a custom formulation. DRCOAT® ECS, ECA and EZ systems are ready-to-use enteric options that work well when a standard release point is acceptable and speed matters more than customization.

Does the product need immediate release, moisture protection or a cosmetic finish?

DRCOAT® is the natural fit here, since it is built as a ready-to-use film coating system for tablets. The FCS, FCA and SEAL systems cover immediate release. The MB-S and MB-A systems form the moisture barrier coating system portion of the range. The PEARL, GLOW and CLR systems cover specialty cosmetic finishes. DRUGCOAT® is not built for these functions, since its polymers are designed around modified release rather than appearance or basic protection.

Applications by Requirement

‍

Common Challenges

Assuming enteric coating means the same product either way.

Enteric protection is available in both ranges, but the underlying decision is about formulation control, not the release type itself. A formulator who only checks the release requirement can end up requesting the wrong range.

Underestimating the formulation work DRUGCOAT® requires.

Raw polymer systems need development time before they behave predictably in production. A team expecting a quick turnaround should confirm this upfront rather than discovering it mid-project.

Not accounting for the process setup each range requires.

DRUGCOAT® formulation work typically needs in-house mixing and dispersion capability along with the QC testing to validate a custom batch. DRCOAT® arrives pre-mixed and does not require that same equipment. A team that evaluates only the coating material and not the process capability behind it can be surprised by which range actually fits their existing setup.

Formulation Insights

The clearest way to make this decision is to start with the function the coating needs to perform, not with which range sounds more suited to a serious pharmaceutical product. A basic film coat for a stable, non-sensitive tablet does not need the complexity of a raw functional polymer. A sustained release product does not have a ready-to-use shortcut available.

Where enteric protection is required and the release point can be standard, DRCOAT® often gets a product to market faster with less development risk. Where the release point must be precise or unusual, DRUGCOAT® is worth the additional formulation time.

‍

FAQ

1. Can DRCOAT® be used for sustained release products?

No. DRCOAT® does not currently include a ready-to-use sustained release system. DRUGCOAT® RL, RS and NE series polymers are the only option for this function.

2. Is DRUGCOAT® always more expensive than DRCOAT®?

Not necessarily in material cost, but it typically requires more formulation development time, which adds to the overall project cost and timeline.

3. Can I switch from DRUGCOAT® to DRCOAT® partway through development?

Only if the underlying functional requirement matches what DRCOAT® offers. If the product needs sustained release or taste masking, DRUGCOAT® remains the only option regardless of development stage.

4. Does DRCOAT® offer less consistent results than DRUGCOAT®?

No. DRCOAT® systems are pre-formulated specifically to reduce batch to batch variability. Consistency is one of the main reasons formulators choose a ready-to-use system.

5. Which range should I sample first if I am not sure what the product needs?

Confirm the functional requirement first, sustained release, taste masking, enteric protection or basic film coating, before requesting samples. This avoids evaluating the wrong range and having to restart the process.

Conclusion

The choice between DRCOAT® and DRUGCOAT® is not about which range is more advanced. It is about whether the product needs a functional polymer built for a specific release mechanism or a pre-formulated system built for speed and consistency.

As a tablet coating polymer manufacturer, we supply both ranges, backed by EXCiPACT GMP certification, US DMF registration and WHO cGMP compliance. As a polymer excipient manufacturer, we can help match the right range to the actual requirement before sampling begins.

Not Sure Which Coating System Fits Your Product? Talk to Us.

Tell us what the coating needs to do, sustained release, taste masking, enteric protection or a standard film coat. We will recommend the right range for your formulation.

Write to us at contact@vikramthermo.com

‍

‍

‍